Evidence-based multi-peptide stacking protocols with detailed dosing schedules, timing, and expected outcomes.
Maximum tissue repair and recovery
Growth hormone optimization for body composition and recovery
Anti-aging, telomere support, and cellular rejuvenation
Enhanced memory, focus, and neuroprotection
Weight management and metabolic optimization
Comprehensive immune system enhancement
Comprehensive recovery from surgery or major injury
Skin rejuvenation, wound healing, and comprehensive tissue regeneration
Maximum tissue repair and recovery
The most popular recovery protocol, combining BPC-157 and TB-500 for synergistic healing of tendons, ligaments, muscles, and connective tissue. Named for its remarkable regenerative effects.
Gastric Pentadecapeptide
Inject subcutaneously near injury site for local effects
Actin-Sequestering Peptide
Loading phase: 2x/week for 4 weeks, then 1x/week maintenance
BPC-157: Daily SC injection near injury site. TB-500: 2x per week SC injection. Both can be injected simultaneously in separate sites.
Significant reduction in injury pain within 2–3 weeks. Accelerated healing of tendons and ligaments. Improved range of motion. Most users report 50–70% improvement in chronic injuries within 6 weeks.
This protocol uses research peptides not approved for human use. Consult a healthcare provider. Source from reputable suppliers with CoA verification. Monitor for any adverse reactions.
Growth hormone optimization for body composition and recovery
The gold standard GH optimization protocol combining CJC-1295 No DAC (GHRH analog) with Ipamorelin (GHRP) for synergistic GH release. Produces 3–5x greater GH pulse than either peptide alone while maintaining physiological pulsatility.
Growth Hormone Releasing Hormone Analog
Always combine with Ipamorelin — inject simultaneously
Growth Hormone Releasing Peptide (GHRP)
Most important dose is bedtime to amplify natural GH pulse
CJC-1295 No DAC: 2–3x daily (with Ipamorelin). Ipamorelin: 2–3x daily (morning, afternoon, bedtime). Bedtime dose is most important — aligns with natural GH pulse.
Improved sleep quality within 1–2 weeks. Improved recovery within 3–4 weeks. Body composition changes (lean mass gain, fat loss) typically visible at 8–12 weeks. Improved skin quality and energy levels.
Monitor IGF-1 levels every 3 months. Administer on empty stomach for best results. Avoid carbohydrates 30 minutes before and after injection. Hypothyroidism should be treated before starting.
Anti-aging, telomere support, and cellular rejuvenation
A comprehensive longevity protocol combining Epithalon (telomerase activator), GHK-Cu (gene expression regulator), and Thymosin Alpha-1 (immune optimization). Designed for twice-yearly use to support the hallmarks of aging.
Tetrapeptide / Telomerase Activator
Traditional Khavinson protocol: 10 mg/day for 10 days, twice yearly
Copper Peptide / Gene Regulator
Subcutaneous injection; topical can be used concurrently for skin
Thymic Peptide / Immunomodulator
Standard Zadaxin clinical dose
Epithalon: Daily for 10 days. GHK-Cu: Daily for 10 days. Thymosin Alpha-1: Every other day for 10 days. All administered in the morning.
Improved sleep quality and circadian rhythm. Enhanced immune function. Improved skin quality and wound healing. Long-term benefits on cellular aging markers. Results accumulate over multiple annual courses.
This protocol is based on Khavinson's research protocols. Epithalon should not be used with active malignancy. GHK-Cu should not be used with Wilson's disease.
Enhanced memory, focus, and neuroprotection
A nootropic protocol combining Semax (BDNF upregulator) and Selank (anxiolytic) for enhanced cognitive performance, reduced anxiety, and improved neuroplasticity. Both are approved in Russia for cognitive and anxiety disorders.
ACTH Analog / Nootropic
Intranasal preferred; tilt head back, spray while inhaling gently
Anxiolytic Heptapeptide
Can be used as needed for acute anxiety or on a scheduled basis
Semax: Morning intranasal. Selank: Morning and/or afternoon intranasal. Both can be used on the same day. Take breaks every 4 weeks.
Reduced anxiety within days. Improved focus and mental clarity within 1 week. Enhanced memory consolidation over 2–4 weeks. Improved stress resilience.
Semax has stimulant properties — avoid evening dosing. Selank can be used throughout the day. Both are approved in Russia but are research chemicals in most other countries.
Weight management and metabolic optimization
A medically supervised protocol using GLP-1 agonist therapy (semaglutide or tirzepatide) for significant weight reduction and metabolic improvement.
GLP-1 Receptor Agonist
Titrate: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg, each step 4 weeks
Semaglutide: Once weekly SC injection. Titrate dose monthly. Dietary and lifestyle modifications are essential.
Average 14.9% weight loss with semaglutide (STEP 1 trial). Average 20.9% weight loss with tirzepatide (SURMOUNT-1). Improved HbA1c, blood pressure, and lipids. Cardiovascular risk reduction.
REQUIRES physician supervision and prescription. Not for use in MTC or MEN2. Titrate slowly to minimize GI side effects. Monitor for pancreatitis. Lifestyle modifications are essential for long-term success.
Comprehensive immune system enhancement
A protocol combining Thymosin Alpha-1 (the gold standard immunomodulator) with BPC-157 (for gut-immune axis support) to comprehensively optimize immune function.
Thymic Peptide / Immunomodulator
Standard Zadaxin clinical protocol
Gastric Pentadecapeptide
Supports gut-immune axis and reduces systemic inflammation
Thymosin Alpha-1: Twice weekly SC injection. BPC-157: Daily SC injection. Can be injected at the same time in separate sites.
Improved immune markers within 4 weeks. Enhanced vaccine response. Improved gut health and gut-immune axis function. Reduced frequency of infections.
Thymosin Alpha-1 is approved in 35+ countries but is a research chemical in the US. BPC-157 is a research chemical. Consult a healthcare provider. Not recommended for organ transplant recipients.
Comprehensive recovery from surgery or major injury
An advanced protocol for post-surgical recovery or major injury, combining BPC-157, TB-500, and CJC-1295 No DAC/Ipamorelin for maximal tissue healing, reduced inflammation, and enhanced recovery through GH optimization.
Gastric Pentadecapeptide
Local injection near surgical/injury site when possible
Actin-Sequestering Peptide
Provides systemic healing complement to local BPC-157 effects
Growth Hormone Releasing Hormone Analog
Combine with Ipamorelin — inject simultaneously
Growth Hormone Releasing Peptide (GHRP)
Amplifies GH pulse for enhanced recovery
BPC-157: Daily. TB-500: 2x/week (loading), 1x/week (maintenance). CJC-1295 No DAC + Ipamorelin: 2x daily (morning and bedtime).
Significantly accelerated healing timeline. Reduced post-operative pain and inflammation. Improved tissue quality. Enhanced sleep and recovery.
Advanced protocol — consult a healthcare provider. Not a replacement for standard medical care. Inform your surgeon before use. Monitor for any adverse reactions.
Skin rejuvenation, wound healing, and comprehensive tissue regeneration
A protocol using the GLOW Blend (GHK-Cu / BPC-157 / TB-500) for comprehensive regenerative support, with particular emphasis on skin quality, collagen synthesis, and anti-aging effects.
Regenerative Blend
GLOW Blend: GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg
Coenzyme / NAD+ Precursor
Optional addition for enhanced anti-aging and cellular energy effects
GLOW Blend: Daily SC injection. Optional: GHK-Cu topical cream applied to skin daily. Optional: NAD+ IV or SC weekly.
Improved skin quality and elasticity within 4–6 weeks. Enhanced wound healing. Reduced inflammation. Improved hair quality. Anti-aging gene expression changes.
GHK-Cu component should not be used with Wilson's disease. All components are research chemicals. Topical GHK-Cu can be used concurrently for enhanced skin effects.
Members-Only Access
Access advanced peptide education, protocol insights, and research-based information curated for informed users. Create a free account or log in to continue.
Please acknowledge the disclaimer above to continue.